Skip to content
B
BiotechEdge
Start 14-Day Free Trial

Accolade + Transcarent

closed

$ACCD acquired by Transcarent for $621M

Deal Summary

Deal Value
$621M
Price/Share
$7.03
Announced
Jan 8, 2025
Closed
Apr 8, 2025

Fund Positioning

1 of 20 tracked specialist biotech funds held $ACCD — based on SEC 13F filings.

FundSharesValueEntryAt Announcement
Deerfield Management132.6M$130.6MMar 2025No
← All biotech acquisitions